We compared the prevalence of oncogenic co-alterations in ERBB2mut (excluding samples with ERBB2 co-amplification) versus ERBB2wt (non-mutated and non-amplified) tumors among the five major ERBB2mut tumor types (Supplementary Fig. S8). The gene discussed is ERBB2; the disease is neoplasm.